Atreya Dash, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 4033 Talbot Rd S, Ste 560, Renton, WA 98055 Phone: 425-656-5365 Fax: 425-656-5325 |
Dr. Jeff Cooper, DO PLLC Urology Medicare: Accepting Medicare Assignments Practice Location: 4300 Talbot Road S, Suite 104, Renton, WA 98055 Phone: 425-228-1123 Fax: 425-228-5791 |
Dr. Daniel R Simon, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 4033 Talbot Rd S, Ste 560, Renton, WA 98055 Phone: 425-656-4110 Fax: 425-656-4112 |
Shan Dong, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 4033 Talbot Rd S Ste 500, Renton, WA 98055 Phone: 425-656-5365 Fax: 425-656-5325 |
News Archive
A workplace program designed to teach employees to act more like consumers when they make health care decisions, for example, by finding and evaluating health information or choosing a benefit plan, also improved exercise, diet and other health habits, according to a new study in the latest issue of the American Journal of Health Promotion.
Autism has a strong genetic basis, but so far efforts to identify the responsible genes have had mixed results. The reason for this is that autism is influenced by many different genes, and different genes are involved in different individuals, making it hard to find the common genetic ground between patients.
Agendia, a world leader in molecular cancer diagnostics, today announced that its breast cancer product offering, consisting of breast cancer recurrence test MammaPrint(R), and TargetPrint(TM), has been expanded with BluePrint (TM) to report important additional information on tumor subtypes.
Starfish have arms, spines and a mouth on the underside of its body. But what scientists are finding really interesting is the sticky goo which is secreted when the Starfish feels threatened. The slime contains properties which may prove invaluable in treating certain kinds of inflammatory illnesses.
Regado Biosciences, Inc., a biopharmaceutical company focused on the development of actively controllable therapeutics, today announced that the United States Food and Drug Administration has designated REG1 for anticoagulant therapy to be used in patients with coronary artery disease during percutaneous coronary interventions (PCI) as a Fast Track development program.
› Verified 5 days ago